Non-conventional signal transduction by type I interferons:: The NF-κB pathway

被引:58
作者
Du, Ziyun [1 ]
Wei, Lai [1 ]
Murti, Aruna [1 ]
Pfeffer, Susan R. [1 ]
Fan, Meiyun [1 ]
Yang, Chuan He [1 ]
Pfeffer, Lawrence M. [1 ]
机构
[1] Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Univ Tennessee Canc Inst, Memphis, TN 38163 USA
关键词
signal transduction; interferon; NF-kappa B; JAK; STAT; gene expression;
D O I
10.1002/jcb.21535
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Type I interferons (IFNs) regulate diverse cellular functions by modulating the expression of IFN-stimulated genes (ISGs) through the activation of the well established signal transduction pathway of the Janus Kinase (JAK) and signal transducers and activators of transcription (STAT) proteins. Although the JAK-STAT signal transduction pathway is critical in mediating IFN's antiviral and antiproliferative activities, other signaling pathways are activated by IFNs and regulate cellular response to IFN. The NF-kappa B transcription factor regulates the expression of genes involved in cell survival and immune responses. We have identified a novel IFN mediated signal pathway that leads to NF-kappa B activation and demonstrate that a subset of ISGs that play key roles in cellular response to IFN is regulated by NF-kappa B. This review focuses on the IFN-induced NF-kappa B activation pathway and the role of NF-kappa B in ISG expression, antiviral activity and apoptosis, and the therapeutic application of IFN in cancer and infectious disease.
引用
收藏
页码:1087 / 1094
页数:8
相关论文
共 30 条
[1]
IκB-NF-κB structures:: At the interface of inflammation control [J].
Baeuerle, PA .
CELL, 1998, 95 (06) :729-731
[2]
Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers [J].
Bonizzi, G ;
Bebien, M ;
Otero, DC ;
Johnson-Vroom, KE ;
Cao, YX ;
Vu, D ;
Jegga, AG ;
Aronow, BJ ;
Ghosh, G ;
Rickert, RC ;
Karin, M .
EMBO JOURNAL, 2004, 23 (21) :4202-4210
[3]
Shaping the nuclear action of NF-κB [J].
Chen, LF ;
Greene, WC .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (05) :392-401
[4]
RNA-dependent protein kinase PKR is required for activation of NF-κB by IFN-γ in a STAT1-independent pathway [J].
Deb, A ;
Haque, SJ ;
Mogensen, T ;
Silverman, RH ;
Williams, BRG .
JOURNAL OF IMMUNOLOGY, 2001, 166 (10) :6170-6180
[5]
The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways [J].
Dejardin, E ;
Droin, NM ;
Delhase, M ;
Haas, E ;
Cao, YX ;
Makris, C ;
Li, ZW ;
Karin, M ;
Ware, CF ;
Green, DR .
IMMUNITY, 2002, 17 (04) :525-535
[6]
VIRUS INTERFERENCE .1. THE INTERFERON [J].
ISAACS, A ;
LINDENMANN, J .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1957, 147 (927) :258-267
[7]
The IKKNF-κB system:: A treasure trove for drug development [J].
Karin, M ;
Yamamoto, Y ;
Wang, QM .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (01) :17-26
[8]
Inflammation-associated cancer:: NF-κB is the lynchpin [J].
Li, QT ;
Withoff, S ;
Verma, IM .
TRENDS IN IMMUNOLOGY, 2005, 26 (06) :318-325
[9]
NF-κB in cancer:: a marked target [J].
Lin, A ;
Karin, M .
SEMINARS IN CANCER BIOLOGY, 2003, 13 (02) :107-114
[10]
Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies [J].
Panwalkar, A ;
Verstovsek, S ;
Giles, F .
CANCER, 2004, 100 (08) :1578-1589